These results indicate that sodium butyrate significantly increases the expression of intestinal Occludin, Claudin-1, and ZO-1 proteins, improves intestinal permeability, and reduces serum LPS levels, thus reducing liver inflammation and improving alcohol-induced hepatic function impairment. This evidence concerns the gene CLDN1 and medical procedure.